Takeda Opens China Clinical Trial Center in Shanghai
Takeda Pharma, the largest pharma in Japan, has officially opened its new headquarters for clinical trials in China, called the Takeda Shanghai Development Center. The new facility will be responsible for Takeda’s general medicine clinical trials in China and oncology treatments across Asia. The company said the new facility underscores its commitment to Asia and China in particular. More details.... Stock Symbol: (TSE: 4502) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here